Guarding Retina Cells Save Eyesight

Retinal cells have a remarkable ability to wall off damage caused in the retina to save the eyesight, found a team of neuroscientists led by UConn Health reports. This finding is published in the Proceedings of the National Academy of Sciences.

The retina is a delicate tissue in the back of the eye that detects light and transmits images to the brain. Muller glia are very long cells that span the thickness of the retina and provide mechanical strength, supporting the neurons and light receptors that detect light, shape, and color.

Age Related Macular Degeneration (AMD) - Causes, Symptoms, Diagnosis, Treatment & Prevention
Age related macular degeneration is a disease of the elderly, wherein the macula or the central part of the retina gets affected, leading to loss of vision.

‘Retinal cells are the first to respond when protein changes related to retinal injury occur.’

Tweet it Now

Researchers have discovered that the endfeet, a specialized zone in retinal cells where proteins become modified when the retina is under stress. These endfeet are at the opposite end of the retina, quite a distance from light receptors.

Researchers proposed that this segregation of the endfeet and light receptors may permit light detection to continue even as the retina responds to stress.

The modification of proteins Mohan’s lab has been studying is called citrullination. In citrullination, the amino acid arginine is changed into citrulline.

Routine Eye Examination
A comprehensive eye exam can take an hour or more, depending on the doctor and the number and complexity of tests required to fully evaluate vision and the health of the patient’s eyes.

Because in the early stages of stress or disease, the citrullinated proteins stay sequestered in the Muller cells' endfeet, Mohan calls this area the citrullination bunker. But if this bunker is chronically engaged, then the overabundance of citrullinated proteins reaches other parts of the retina.

Muller cells in human age-related macular degeneration (AMD) and mouse models of retinal degeneration reveal citrullinated proteins extending out of the endfeet and spreading throughout the cells.

Imitation of Blood-retinal Barrier to Reduce Animal Testing
An imitation of the human blood-retinal barrier has been developed on a microfluidic chip. This may reduce the use of animals for testing in research.

Citrullination may have many effects on Muller glial cells which are only just being understood. For example, arginine is positively charged, while citrulline is not.

The loss of the positive charges is permanent, and may irreversibly change the flexibility or other mechanical properties of the Muller glial cells. This may cause the Muller cells to become incapable of adapting to fluid build-up when the retina swells up under stress.

Eye Drops to Replace Injections for Retinal Diseases
A new eye drop called Sylentis SYL136001v10 that may replace injections for retinal diseases like macular degeneration, diabetic retinopathy, has been developed

Alternatively, it is possible the citrullinated proteins could appear foreign to the body and draw the attention of the immune system, potentially beginning autoimmune disease. Turning off citrullination in the end feet bunker could delay or avoid these problems and preserve eyesight for longer.

They also identified that the endfeet citrullination process is controlled by an enzyme known as peptidyl arginine deiminase-4 (PAD4). Small molecule inhibitors of PAD4 have been developed for other types of citrullination-dependent diseases, such as rheumatoid arthritis.

Researchers believe that such therapeutic agents could be applied to reduce citrullination at early stages of AMD and spare the retina of undesired responses to this protein modification.

Source-Medindia